Jump to Navigation
Mohr Davidow Ventures

Tethys Bioscience Nabs $25M in New Financing

November 9, 2009
Related: , Tethys Bioscience

GenomeWeb: The firm plans to use the funds to expand sales strategies for its type 2 diabetes test.

Read the full article here >> 

Main menu

  • About Us
  • Companies
  • News
  • Contact
  • Investor Login
Twitter Facebook LinkedIn

More News

April 29th, 2013
RainDance Secures $20M, and a Believer in Myriad Genetics
April 22nd, 2013
Coupa Gains on Competitors in Expense Management, Driven by CEO’s Unusual Vision of SaaS and Success
April 17th, 2013
Start-up Sensity CEO Hugh Martin and Programmer Kevin Hester are Back Together Again with an Audacious LED Plan
April 15th, 2013
Where Have All the Big VC Deals Gone?

©2013 Mohr Davidow Ventures  |  3000 Sand Hill Road, 3-290  |  Menlo Park, CA 94025  |  Telephone: (650) 854-7236  |  Fax: (650) 854-7365